Sotac Pharmaceuticals Limited
ListedSMEPharmaceuticals & Healthcare · NSE
Incorporated in 2015, Sotac Pharmaceuticals Limited, part of the Gujarat-based SOTAC Group, is engaged in manufacturing pharmaceutical products for various marketers on a loan license and contract manufacturing basis. Serving over 162 corporate clients, the company operates primarily on a principal-to-principal model. Established in 2017, its manufacturing facility has an annual capacity of 90 crore tablets and 14 crore capsules. Backed by promoters with over 59 years of combined industry experience, Sotac Pharmaceuticals continues to expand and strengthen its presence in the pharmaceutical sector.
Price Band
₹105 – ₹111
Issue Size
₹33.30 Cr
Lot Size
1200 shares
GMP
—
Est. Listing
₹111
at current GMP
Subscribed
1.60x
overall
Open
29 Mar 2023
Close
3 Apr 2023
Allotment
10 Apr 2023
Refund
11 Apr 2023
Demat Credit
12 Apr 2023
Listing
13 Apr 2023
Last updated 12 days ago
Overall Subscription
1.60x
Total Demand
QIB Multiplier
0.00x
Institutions & Funds
NII / HNI
0.00x
High Net-Worth
Retail (RII)
0.00x
Individual Bidders
Category-Wise Subscription Breakup
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| Qualified Institutional (QIB) | 1,500,000 | — | 0.00x |
| Non-Institutional (NII / HNI) | 450,000 | — | 0.00x |
| Retail Individual (RII) | 1,050,000 | — | 0.00x |
| Total | 3,000,000 | 0 | 1.60x |
Application-Wise Breakup
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 875 | 1,400 | 1.60x |
| HNIs (10L +) | 6 | 10 | 1.67x |
| HNIs (2-10L) | 27 | 43 | 1.59x |
| Total Applications | 908 | 1,453 | 1.60x |
Day-Wise Subscription Progress
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
About Sotac Pharmaceuticals Limited Public Issue & Market Profile
Sotac Pharmaceuticals Limited is bringing an initial public offering (IPO) in the Pharmaceuticals & Healthcare sector with an aggregate issue size of ₹33.3 Crores. The shares are offered at a price band of ₹105 to ₹111 per equity share on NSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Bidding & Quota Instructions:
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1200 shares (approx. ₹1,33,200 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment Reconciliation Schedule:
Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2023-04-12, while un-allotted funds or UPI block mandates will be released on 2023-04-11.
Frequently Asked Questions
What is Sotac Pharmaceuticals Limited IPO GMP today?
Currently, Sotac Pharmaceuticals Limited IPO Grey Market Premium (GMP) is not actively quoted or is quoted flat at ₹0. The shares are expected to list close to the issue price band of ₹105 to ₹111 per equity share.
What is the expected profit per lot for Sotac Pharmaceuticals Limited IPO?
The retail lot size is 1200 shares requiring a minimum application amount of ₹1,33,200. Expected listing price is ₹111 per equity share.
What is the issue size and price band for Sotac Pharmaceuticals Limited IPO?
The Sotac Pharmaceuticals Limited IPO aggregate issue size is ₹33.3 Crores with an equity price band set at ₹105 to ₹111 per equity share. The retail lot size is 1200 shares requiring a minimum capital outlay of approx. ₹1,33,200.
How can I check Sotac Pharmaceuticals Limited IPO live subscription demand?
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 1.60x (Retail: 0.00x, QIB: 0.00x, NII: 0.00x). You can track live multiples directly on our dedicated subscription page.
Where and when will Sotac Pharmaceuticals Limited IPO allotment status be published?
The basis of allotment will be published on the official registrar portal (Kfin Technologies Limited) and the BSE status verification website on or around 2023-04-10. Investors can verify status using PAN card or application number.
When is the listing date for Sotac Pharmaceuticals Limited IPO?
Sotac Pharmaceuticals Limited shares are scheduled to list on NSE on 2023-04-13.